Summary
Background Recent studies suggested a link between long-term exposure to air-pollution and COVID-19 mortality. However, due to their ecological design, based on large spatial units, they neglect the strong localised air-pollution patterns, and potentially lead to inadequate confounding adjustment. We investigated the effect of long-term exposure to NO2 and PM2·5 on COVID-19 deaths up to June 30, 2020 in England using high geographical resolution. Methods We included 38 573 COVID-19 deaths up to June 30, 2020 at the Lower Layer Super Output Area level in England (n=32 844 small areas). We retrieved averaged NO2 and PM2·5 concentration during 2014-2018 from the Pollution Climate Mapping. We used Bayesian hierarchical models to quantify the effect of air-pollution while adjusting for a series of confounding and spatial autocorrelation.
Findings We find a 0·5% (95% credible interval: −0·2%-1·2%) and 1·4% (−2·1%-5·1%) increase in COVID-19 mortality rate for every 1μg/m3 increase in NO2 and PM2·5 respectively, after adjusting for confounding and spatial autocorrelation. This corresponds to a posterior probability of a positive effect of 0·93 and 0·78 respectively. The spatial relative risk at LSOA level revealed strong patterns, similar for the different pollutants. This potentially captures the spread of the disease during the first wave of the epidemic.
Interpretation Our study provides some evidence of an effect of long-term NO2 exposure on COVID-19 mortality, while the effect of PM2·5 remains more uncertain.
Funding Medical Research Council, Wellcome Trust, Environmental Protection Agency and National Institutes of Health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
G.K. is supported by an MRC Skills Development Fellowship [MR/T025352/1]. M.B and T.P are supported by a National Institutes of Health, grant number [R01HD092580-01A1]. J.B. and M.E. are supported by the Pathways to Equitable Healthy Cities grant from the Wellcome Trust [209376/Z/17/Z] and by a grant from the US Environmental Protection Agency (EPA), as part of the Centre for Clean Air Climate Solution (assistance agreement no. R835873). This article has not been formally reviewed by the EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the EPA. The EPA does not endorse any products or commercial services mentioned in this publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Outcome data can be available after a request to PHE. Confounding data and the Rcode are online available on https://github.com/gkonstantinoudis/COVID19AirpollutionEn.
